Unicycive Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Unicycive Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2024.
  • Unicycive Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.16M, a 34.3% increase year-over-year.
  • Unicycive Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$6K, a 99.4% increase from 2021.
  • Unicycive Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.04M, a 326% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.16M +$550K +34.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $17.3M +$16.8M +3465% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q3 2023 $1.61M +$1.61M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $484K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$10.4M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-16
Q3 2022 -$3K +$483K +99.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q4 2021 -$1.04M $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$486K -$410K -539% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$321K -$319K -15950% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$233K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$76K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$2K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.